Innospec Inc. (NASDAQ:IOSP) Insider Philip Curran Sells 300 Shares

Share on StockTwits

Innospec Inc. (NASDAQ:IOSP) insider Philip Curran sold 300 shares of the stock in a transaction that occurred on Friday, June 8th. The stock was sold at an average price of $80.03, for a total value of $24,009.00. Following the completion of the transaction, the insider now directly owns 1,918 shares of the company’s stock, valued at $153,497.54. The sale was disclosed in a filing with the SEC, which is available at this link.

Philip Curran also recently made the following trade(s):

  • On Monday, May 14th, Philip Curran sold 2,000 shares of Innospec stock. The stock was sold at an average price of $73.63, for a total value of $147,260.00.

Innospec opened at $76.55 on Friday, according to Marketbeat.com. The company has a market cap of $1.88 billion, a P/E ratio of 16.53 and a beta of 1.06. Innospec Inc. has a one year low of $54.10 and a one year high of $81.05. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.28 and a current ratio of 2.13.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, May 8th. The specialty chemicals company reported $1.02 EPS for the quarter, topping the Zacks’ consensus estimate of $0.91 by $0.11. The business had revenue of $360.70 million for the quarter, compared to analyst estimates of $308.90 million. Innospec had a return on equity of 14.91% and a net margin of 4.86%. Innospec’s revenue for the quarter was up 22.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.00 EPS. analysts forecast that Innospec Inc. will post 4.4 earnings per share for the current fiscal year.

The firm also recently declared a semiannual dividend, which was paid on Thursday, May 31st. Investors of record on Monday, May 21st were given a dividend of $0.44 per share. The ex-dividend date was Friday, May 18th. This is a positive change from Innospec’s previous semiannual dividend of $0.39. This represents a yield of 1.18%. Innospec’s dividend payout ratio is 37.77%.

A number of brokerages have recently issued reports on IOSP. BidaskClub cut Innospec from a “strong-buy” rating to a “buy” rating in a report on Saturday. Zacks Investment Research raised Innospec from a “hold” rating to a “buy” rating and set a $85.00 target price for the company in a report on Friday, May 18th. ValuEngine cut Innospec from a “strong-buy” rating to a “buy” rating in a report on Wednesday, May 2nd. Finally, Johnson Rice upgraded Innospec from an “accumulate” rating to a “buy” rating in a research report on Tuesday, April 24th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Innospec has an average rating of “Buy” and an average target price of $75.00.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Legal & General Group Plc boosted its position in Innospec by 2.7% in the 1st quarter. Legal & General Group Plc now owns 49,645 shares of the specialty chemicals company’s stock valued at $3,399,000 after buying an additional 1,312 shares during the last quarter. Barclays PLC boosted its position in Innospec by 19.0% in the 1st quarter. Barclays PLC now owns 8,572 shares of the specialty chemicals company’s stock valued at $588,000 after buying an additional 1,367 shares during the last quarter. UBS Group AG boosted its position in Innospec by 69.3% in the 1st quarter. UBS Group AG now owns 2,771 shares of the specialty chemicals company’s stock valued at $190,000 after buying an additional 1,134 shares during the last quarter. Westwood Holdings Group Inc. boosted its position in Innospec by 8.4% in the 1st quarter. Westwood Holdings Group Inc. now owns 398,922 shares of the specialty chemicals company’s stock valued at $27,366,000 after buying an additional 30,850 shares during the last quarter. Finally, Profund Advisors LLC boosted its position in Innospec by 21.4% in the 1st quarter. Profund Advisors LLC now owns 4,452 shares of the specialty chemicals company’s stock valued at $305,000 after buying an additional 786 shares during the last quarter. Hedge funds and other institutional investors own 91.72% of the company’s stock.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply